- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CV SCIENCES Aktie jetzt für 0€ handeln | |||||
| 23.12.25 | CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD | 488 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / December 22, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp... ► Artikel lesen | |
| 14.11.25 | CV Sciences outlines new non-cannabinoid product launches in 2026 while adapting to regulatory changes | 3 | Seeking Alpha | ||
| 13.11.25 | CV Sciences GAAP EPS of $0.00, revenue of $3.26M | 2 | Seeking Alpha | ||
| 13.11.25 | CV Sciences, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 13.11.25 | CV Sciences, Inc. Reports Third Quarter 2025 Financial Results | 260 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / November 13, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp... ► Artikel lesen | |
| 11.11.25 | CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025 | 333 | ACCESS Newswire | SAN DIEGO, CALIFORNIA / ACCESS Newswire / November 10, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing... ► Artikel lesen | |
| 10.10.25 | CV Sciences, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 18.09.25 | CV Sciences, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 27.08.25 | CV Sciences, Inc.: CV Sciences Launches Ignite: A Men's Performance Formula for Vitality, Recovery, Libido & Focus | 505 | ACCESS Newswire | Ignite delivers a powerful blend of proven botanicals along with our award-winning CBD, designed to help men stay strong, sharp, and ready-at work, in the gym, and beyond. SAN DIEGO, CALIFORNIA / ACCESS... ► Artikel lesen | |
| 13.08.25 | CV Sciences, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 13.08.25 | Earnings Call: CV Sciences erzielt im zweiten Quartal 2025 höchste Bruttomarge seit 2019 | 1 | Investing.com Deutsch | ||
| 13.08.25 | CV Sciences Non-GAAP EPS of $0.00, revenue of $3.62M | 2 | Seeking Alpha | ||
| 13.08.25 | CV Sciences, Inc. Reports Second Quarter 2025 Financial Results | 326 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / August 13, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts... ► Artikel lesen | |
| 13.08.25 | CV Sciences, Inc. - 8-K, Current Report | 6 | SEC Filings | ||
| 08.08.25 | CV Sciences, Inc. To Announce Second Quarter 2025 Results On August 13, 2025 | 573 | ACCESS Newswire | SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 8, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in... ► Artikel lesen | |
| 24.06.25 | CV Sciences, Inc. Applauds Governor Abbot's Veto of Senate Bill 3 | 419 | ACCESS Newswire | SAN DIEGO, CALIFORNIA / ACCESS Newswire / June 23, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp... ► Artikel lesen | |
| 14.05.25 | CV Sciences, Inc. Reports First Quarter 2025 Financial Results | 381 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / May 14, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts... ► Artikel lesen | |
| 10.05.25 | CV Sciences, Inc. to Announce First Quarter 2025 Results on May 14, 2025 | 449 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / May 9, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts... ► Artikel lesen | |
| 27.03.25 | CV Sciences, Inc. Reports Fiscal Year-End 2024 Financial Results | 532 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / March 27, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts... ► Artikel lesen | |
| 26.03.25 | CV Sciences, Inc.: CV Sciences Unveils Lunar Fox Food Co., an All-New Line of Plant-Based Foods | 1.018 | ACCESS Newswire | The innovative product line offers a unique choice of plant-based, 100% natural alternatives to the foods everyone loves. SAN DIEGO, CA / ACCESS Newswire / March 26, 2025 / CV Sciences, Inc. (OTCQB:CVSI)... ► Artikel lesen |
1 2 Weiter >>
22 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| JOHNSON & JOHNSON | 189,08 | -0,10 % | Johnson & Johnson's TECVAYLI Shows 71% Risk Reduction In Phase 3 MajesTEC-9 Multiple Myeloma Study | NEW BRUNSWICK (dpa-AFX) - Johnson & Johnson (JNJ) announced positive topline results from the investigational Phase 3 MajesTEC-9 study of TECVAYLI (teclistamab-cqyv) monotherapy. The study demonstrated... ► Artikel lesen | |
| PROCTER & GAMBLE | 124,50 | -0,11 % | P&G warns shareholders about Potemkin's below-market mini-tender offer | ||
| LVMH | 627,80 | +0,18 % | LVMH: Vor entscheidender Marke - doch es gibt 3 Risiken | Nach der starken Rally wächst die Hoffnung auf eine nachhaltige Erholung bei LVMH. Kurz vor der wichtigen 650 Euro-Marke stellt sich nun die Frage: Gelingt der Ausbruch? Geht man nach Barclays, ist... ► Artikel lesen | |
| STEINHOFF INTERNATIONAL | - | - | People Moves: SCOR Names Swiss Re's Forgeron as P&C Chief Underwriting Officer; Hamilton Re Promotes Steinhoff to CUO | ||
| SONY GROUP | 20,890 | +0,29 % | Sony Feature Films To Stream On Netflix Worldwide | TOKYO (dpa-AFX) - Sony Pictures Entertainment has struck a multiyear global Pay-1 licensing agreement with Netflix, significantly expanding their long-running U.S. partnership. Under the deal... ► Artikel lesen | |
| LOREAL | 386,00 | -0,23 % | UBS stuft LOREAL auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat L'Oreal von "Neutral" auf "Buy" hochgestuft und das Kursziel von 367 auf 430 Euro angehoben. Erstmals seit mehr als zwei Jahren dürfte der... ► Artikel lesen | |
| COLGATE-PALMOLIVE | 72,67 | -0,01 % | Demystifying Colgate-Palmolive: Insights From 13 Analyst Reviews | ||
| RECKITT BENCKISER | 70,86 | -1,31 % | Broker tips: Reckitt Benckiser, Liontrust Asset Management | ||
| RATIONAL | 664,00 | +1,30 % | RBC stuft RATIONAL AG auf 'Underperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat das Kursziel für Rational von 590 auf 580 Euro gesenkt und die Einstufung auf "Underperform" belassen. Ein Analystenteam um Mark Fielding stellte... ► Artikel lesen | |
| PANASONIC | 11,850 | +0,64 % | Panasonics günstiger OLED-TV Z80B hängt in einem Punkt sogar LG und Samsung ab | ||
| SHARKNINJA | 126,04 | +1,69 % | Wachstumsausblick überzeugt: TD Cowen bestätigt Kaufempfehlung für SharkNinja | ||
| HERMES INTERNATIONAL | 2.225,00 | 0,00 % | AKTIEN IM FOKUS: Richemont und Luxuswerte schwächeln nach Anfangsgewinnen | ZÜRICH (dpa-AFX Broker) - Die Aktien von Richemont haben am Donnerstag anfängliche Gewinne abgegeben. Mit einem Abschlag von 1,4 Prozent profitierte der Wert nicht von neuen Zahlen. Der Schmuck- und... ► Artikel lesen | |
| DOGNESS INTERNATIONAL | 11,220 | 0,00 % | Dogness International Corporation: Dogness Reports Financial Results for Fiscal Year Ended June 30, 2025 | DONGGUAN, China and PLANO, Texas, Oct. 17, 2025 /PRNewswire/ -- Dogness (International) Corporation ("Dogness" or the "Company") (NASDAQ: DOGZ), a developer and... ► Artikel lesen | |
| TONIES | 10,740 | +0,37 % | EQS-PVR: tonies SE: Release according to article 11 paragraph 6 of the Luxembourg transparency law and section 40 paragraph 1 of the German securities trading act (WpHG) | The Capital Group Companies Inc | EQS Voting Rights Announcement: tonies SE
tonies SE: Release according to article 11 paragraph 6 of the Luxembourg transparency law and section 40 paragraph 1 of the German securities... ► Artikel lesen | |
| LOVESAC | 15,990 | 0,00 % | The Lovesac Company Reports Third Quarter Fiscal 2026 Financial Results | STAMFORD, Conn., Dec. 11, 2025 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) ("Lovesac" or the "Company"), the Designed for Life home and technology brand best known for its Sactionals, The... ► Artikel lesen |
CV SCIENCES INC gehört der Branche Konsumgüter an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CV SCIENCES INC finden Sie auf Wallstreet Online.